PATENT CLAIM ANALYSIS

Application Number: 15754414
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "416000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d 90 ) ranging from 1 μm to 100 μm.

Claim (Index 32):
The capsule according to  claim 31 , wherein the amount of filler(s) is in the range of from 80.0% to 95.0% by weight.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780495', '15852125', '11776012', '15387317', '13736699']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7331794343246828
- 35 USC 102 Novelty (BERT): 0.5137037463598035
- Combined Prediction Score: 0.711231865528195
- Mean Citation Score: 200.706194
- Max Citation Score: 204.72156
- Similarity Product: 119.93756588208676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test